New investigations are underway into the death of Francesca Tuscano, the 32-year-old teacher from Genoa who died from an adverse reaction to the AstraZeneca vaccine administered during the first phase of the Covid vaccination campaign.
Judge Angela Nutini ruled, rejecting the prosecutor's request to dismiss the case and upholding the motion of the family's lawyers, Salvatore Bottiglieri and Federico Bertorello. For the preliminary investigations judge, regardless of the liability of the doctors who actually administered the vaccine, "it appears necessary for the prosecutor to consider conducting further investigative activities deemed useful to identify possible responsibilities in the organization and implementation of the AstraZeneca vaccine campaign, and any conduct that may have contributed to Tuscano's negligent death."
The investigating judge has decided to order new investigations, also in light of the findings of the investigation into the death of Camilla Canepa, the eighteen-year-old also killed by an adverse reaction during the second part of the vaccination campaign. Specifically, the judge cites the meetings of the Technical Scientific Committee: in the one on May 7, 2021, " the case of the girl who died in Genoa was mentioned," the order states, "and subsequently, in the heated discussion, some argued that 'if we had worked differently, this girl would not have died.'" It was further noted that the 'correlation' between thrombosis and the viral vector vaccines administered was "clear," and that the cost-benefit balance makes sense where there are no concrete alternatives, but not where there are, and which at that specific time were represented by the availability of alternative vaccines."
During the subsequent online meeting of the Technical-Scientific Committee on June 11, 2021 , "Dr. Giorgio Palù, then president of AIFA, inadvertently left the microphone open, making the call audible to everyone. He reported the Ministry's insistence that the CTS express a favorable opinion on extending the AstraZeneca and Johnson & Johnson vaccines to the entire population, despite his opposition. We need to question the possible necessity and advisability of at least in the presence of objective factors predisposing to the risk of thrombosis, such as the use of estrogen-progestins (...). In any case, upon vaccination." The new investigations are expected to last five months.
